ArticleHuman molecular genetics2014

SUCLG2 identified as both a determinator of CSF Aβ1-42 levels and an attenuator of cognitive decline in Alzheimer's disease.

Alfredo Ramirez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.